{"id":37309,"date":"2018-07-23T08:33:01","date_gmt":"2018-07-23T06:33:01","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=37309"},"modified":"2018-07-23T19:36:14","modified_gmt":"2018-07-23T17:36:14","slug":"prezzi-farmaci-usa-si-allineano-roche-bayer-e-merck-kgaa","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/prezzi-farmaci-usa-si-allineano-roche-bayer-e-merck-kgaa\/","title":{"rendered":"US drug prices: Roche, Bayer and Merck KGaA line up"},"content":{"rendered":"

Roche, Bayer and Merck KGaA have also decided to freeze drug prices in the US following the intervention of the Trump administration. The three European pharmaceutical companies have therefore made it known that this year they will not raise prices in what represents for them the largest market in the world, in the wake of what has already been announced by Novartis, Pfizer and MSD.
\nSome analysts doubt that this decision will have a significant impact, given that these commitments will temporarily take the various companies away from Trump's attacks, but will leave them ample leeway for adjustments in the coming months.<\/p>\n

\"\"<\/a>The "big chill" of prices<\/strong>
\nNovartis CEO Vas Narasimhan halted price hike in June. A month later, Trump called Pzifer's number one CEO Ian Read after his company hiked prices on July 1. And Pfizer has reversed course, winning the applause of the White House. New Jersey-based MSD also announced price cuts on some drugs, including those for hepatitis C. However, the overall impact could be small given the tiny market shares of these drugs . MSD also announced it will not raise the average net price of other medicines above the annual inflation rate.<\/p>\n

High cost treatments<\/strong>
\nKeytruda, MSD's $13,500-a-month immunotherapy was not on the list of drugs whose price would be cut. According to Thomson Reuters estimates based on analyst forecasts, the therapy is on track to reach $18 billion in sales in 2024.
\n\u201cWith numbers like that, many pharmaceutical companies can take a temporary breather on price hikes,\u201d said Michael Nawrath, an analyst at Zuercher Kantonalbank. \u201cWhy risk what happened to Pzifer and get caught in the eye of the storm? \u2013 asks the expert \u2013 This is clearly a facade adhesion and, if it is not, why not commit to making it last longer, especially since we are already talking about one of the most profitable industries?\u201d<\/p>\n

Source Reuters<\/p>\n

Daily Health Industry \u2013 July 23, 2018<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Anche Roche, Bayer e Merck KGaA hanno deciso di congelare dei prezzi dei farmaci negli Usa in seguito all\u2019intervento dell\u2019Amministrazione Trump. Le tre case farmaceutiche europee hanno dunque fatto sapere che quest\u2019anno non alzeranno i prezzi in quello che rappresenta per loro il pi\u00f9 grande mercato al mondo, sulla scia di quanto gi\u00e0 annunciato da …<\/p>","protected":false},"author":4,"featured_media":28270,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29],"class_list":["post-37309","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/37309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=37309"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/37309\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/28270"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=37309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=37309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=37309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}